Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats

Journal of Clinical Investigation

Volumn 104, Issue 4, 1999, Pages 447-457

  Jiang, Zhen Y ^a   Lin, You Wei ^a   Clemont, Allen ^a   Feener, Edward P ^a   Hein, Katherine D ^a   Igarashi, Masahiko ^a   Yamauchi, Teruaki ^a   White, Morris F ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT HUMAN INSULIN;

ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; HORMONE ACTION; HYPERINSULINEMIA; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASCULAR TISSUE;

EID: 0032719024     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5971     Document Type: Article

References (56)

1. Obata, T., et al. 1996. Insulin signaling and its regulation of system A amino acid uptake in cultured rat vascular smooth muscle cells. Circ. Res. 79:1167-1176.
2. King, G.L., Goodman, D., Buzney, S., Moses, A., and Kahn, C.R 1985. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75:1028-1036.
3. Zeng, G., and Quon, M.J. 1996. Insulin-stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98:894-898.
4. Tamaroglio, T.A., and Lo, C.S. 1994. Regulation of fibronectin by insulin-like growth factor-1 in cultured rat thoracic smooth muscle cells and glomerular mesangial cells. Exp. Cell Res. 21:338-346.
5. Anderson, P.W., et al. 1996. Insulin and angiotensin II are additive in stimulating TGFβ 1 and matrix mRNAs in mesangial cells. Kidney Int. 30:745-753.
6. Kuboki, K., et al. 1998. Mechanism of insulin's effect on endothelial nitric oxide synthase (eNOS) expression in vivo and in vitro. Diabetes. 47(Suppl. 1):A24. (Abstr.)
7. Steinberg, H.O., Brechtel, G. Johnson, A., Fineberg, N., and Baron, A.D. 1994. Insulin-mediated skeletal muscle vasodilacion is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172-1179.
8. Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L., and Nicod, P. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94:2511-2515.
9. Reaven, G.M. 1993. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu. Rev. Med. 44:121-131.
10. Despres, J.P., et al. 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:952-957.
11. Howard, G., et al. 1996. Insulin sensitivity and atherosclerosis. Circulation. 93:1809-1817.
12. Steinberg, H.O., et al. 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97:2601-2610.
13. DeFronco, R.A., Cooke, C.R., Andres, R., Faloona, G.R., and Davis, P.J. 1975. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 55:845-855.
14. Anderson, E.A., Hoffman, R.P., Balon, T.W., Sinkey, C.A., and Mark, A.L. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246-2252.
15. Kasuga, M.F., Karlsson, A., and Kahn, C.R. 1982. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science. 215:185-186.
16. Sun, X.J., et al. 1991. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:73-77.
17. Sun, X.J., et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-177.
18. Skolnik, E.Y., et al. 1993. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12:1929-1936.
19. Myers, M.G. Jr., et al. 1992. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA. 89:10350-10354.
20. Cheatham, B., et al. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 s6 kinase, DNA synthesis and glucose transporter translocation. Mol. Cell. Biol 14:4902-4911.
21. Haruta, T., et al. 1995. Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J. Biol. Chem. 270:27991-27994.
22. Shepherd, P.R., Nave, B.T., and Siddle, K. 1995. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wort-mannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 305:25-28.
23. Mendez, R., Myers, M.G. Jr., White, M.F., and Rhoads, R.E. 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phospharidylinositol 3-kinase. Mol. Cell. Biol. 16:2857-2864.
24. Skolnik, E.Y., et al. 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science. 260:1953-1955.
25. Myers, M.G. Jr., et al. 1994. Role of 1RS-1-GRB-2 complexes in insulin signaling. Mol. Cell. Biol. 14:3577-3587.
26. Sale, E.M., Atkinson, P.C., and Sale, G.J. 1995. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 14:674-684.
27. Jhun, B.H., et al. 1995. Signal transduction pathways leading to insulin-induced early gene induction. Biochemistry. 34:7996-8004.
28. Kim, S.J., and Kahn, C.R. 1997. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. Biochem. J. 323:621-627.
29. King, G.L., and Johnson, S.M. 1985. Receptor-mediated transport of insulin across endothelial cells. Science. 227: 1583-1586.
30. Jiang, Z.Y., et al. 1999. Endothelin-1 modulates insulin signaling through PI 3-kinase pathway in vascular smooth muscle cells. Diabetes. 48:1120-1130.
31. Xi, X.P., Graf, K., Goetze, S., Hsueh, W.A., and Law, R.E. 1997. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett. 417:283-286.
32. de Souza, C.J., Hirshman, M.F., and Horton, E.S. 1997. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes. 46:1257-1263.
33. Folli, F., Saad, M.J., Backer, J.M., and Kahn, C.R. 1993. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92:1787-1794.
34. Brozinick, J.T., Jr., and Birnbaum, M.J. 1998. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J. Biol. Chem. 273:14679-14682.
35. Bray, G.A. 1977. The Zucker-fatty rat: a review. Fed. Proc. 36:148-153.
36. Soos, M.A., Field, C.E., and Siddle, K. 1993. Purified hybrid insulin/insulin-like growth factot-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290:419-426.
37. Heydrick, S.J., et al. 1993. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J. Clin. Invest. 91:1358-1366.
38. Anai, M., et al. 1998. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes. 47:13-23.
39. Freidenberg, G.R., Henry, R.R., Klein, H.H., Reichart, D.R., and Olefsky, J.M. 1987. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J. Clin. Invest. 79:240-250.
40. Goodyear, L.J., et al. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204.
41. Kerouz, N.J., Horsch, D., Pons, D., and Kahn, C.R. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of obese diabetic (ob/ob) mouse. J. Clin. Invest. 100:3164-3172.
42. Clark, J.B., and Clark, C.M., Jr. 1982. Age-related changes in insulin receptor regulation in liver membranes from Zucker fatty rats. Endocrinology. 111:964-969.
43. Hurrell, D.G., Pedersen, O., and Kahn, CR. 1989. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats. Endocrinology. 125:2454-2462.
44. Caro, J.F., et al. 1987. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79:1330-1337.
45. Hotamisligil, G.S., Budavari, A., Murray, D., and Spiegelman, B.M. 1994. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94:1543-1549.
46. Chin, J.E., Dickens, M., Tavare, J.M., and Roth, R.A. 1993. Overexpression of protein kinase C isoenzymes α β γ and ε in cells overexpressing the insulin receptor: Effects on receptor phosphorylation and signaling. J. Biol. Chem. 268:6338-6347.
47. Pillay, T.S., Xiao, S., and Olefsky, J.M. 1996 Glucose-induced phosphorylation of the insulin receptor. J. Clin. Invest. 97:613-620.
48. Avignon, A., et al. 1996. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes. 45:1396-1404.
49. Worm, D., Handberg, A., Hoppe, E., Vinten, J., and Beck-Nielsen, H. 1996. Decreased skeletal muscle phosphotyrosine phospharase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed europium fluorescence. Diabetologia. 39:142-148.
50. Kusari, J., Kenner, K.A., Suh, K.I., Hill, D.E., and Henry, R.R. 1994. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phospharase 1B protein content are associated with insulin action and resistance. J. Clin. Invest. 93:1156-1162.
51. Ahmad, F., Azevedo, J.L., Cortright, R., Dohm, G.L., and Goldstein, B.J. 1997. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 100:449-458.
52. Boden, G., Chen, X., Ruiz, J., White, J.V., and Rossetti, L 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-2446.
53. Roden, M., et al. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97:2859-2865.
54. Folli, F., Kahn, C.R., Hansen, H., Bouchie, J.L., and Feener, E.P. 1997. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J. Clin. Invest. 100:2158-2169.
55. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:109-142.
56. Banskota, N.K., Taub, R., Zellner, K., and King, G.L. 1989. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol. Endocrinol. 3:1183-1190.